Amyris

Amyris R&D Expenses

Delisted·May 7, 2024

The Research & Development Expenses of Amyris (AMRSQ) as of Nov 20, 2026 is 110.22 M USD. In the previous year, Research & Development Expenses was 94.29 M USD — a change of 16.89% (higher).

R&D Expenses

110.22 MUSD

YoY

16.89%

Last updated:

Research & Development Expenses of Amyris is 2022 110.22 M USD. Research & Development Expenses of Amyris was 2021 94.29 M USD. It decreases by 16.89% higher compared to the previous year.

The Amyris R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2015
44.60 M USD
Jan 1, 2016
51.40 M USD
Jan 1, 2017
57.50 M USD
Jan 1, 2018
67.80 M USD
Jan 1, 2019
71.46 M USD
Jan 1, 2020
71.68 M USD
Jan 1, 2021
94.29 M USD
Jan 1, 2022
110.22 M USD
The Amyris R&D Expenses history
YEARR&D ExpensesYoY
110.22 MUSD+16.89%
94.29 MUSD+31.55%
71.68 MUSD+0.30%
71.46 MUSD+5.40%
67.80 MUSD+17.91%
57.50 MUSD+11.87%
51.40 MUSD+15.25%
44.60 MUSD-10.26%
49.70 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amyris Stock analysis

What does Amyris do? Amyris Inc. is a US-based company specializing in the production of sustainable products. It was founded in 2003 and is headquartered in Emeryville, California. The company aims to promote sustainability in daily life and reduce dependence on fossil fuels. Amyris' business model is based on the discovery and development of biological microorganisms capable of converting sugars and other carbohydrates into valuable products such as fuels, chemicals, and flavors. This technology, known as synthetic biology, was first used for the production of artemisinin, which is used against malaria. Over time, Amyris has expanded its portfolio and specialized in the production of sustainable products for the cosmetics, biofuel, food, and chemical industries. Leading products include Biosolve, an environmentally friendly degreasing solution for the industry, Neossance, a plant-based moisturizer for the cosmetics industry, and Biofene, a bio-based fuel. To produce its products, the company has formed partnerships with various organizations around the world. For example, it has partnered with Total, a French oil and gas company, to establish joint ventures for the production of biofuels. Amyris has also expanded its business by developing a platform for synthetic biology that allows other industry players to develop custom organisms for production processes. This new business model has brought the company into new markets such as the medical and energy sectors. In 2020, the COVID-19 pandemic posed challenges for the company as demand for some products declined. In response, Amyris shifted its production to disinfectants to meet the increased demand for these products. Overall, Amyris has become a leading company in sustainable production and is committed to promoting innovations in synthetic biology to have a positive impact on the environment. Amyris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amyris stock

Research & Development Expenses of Amyris is 110.22 M USD in 2022.

Research & Development Expenses of Amyris changed from 94.29 M USD to 110.22 M USD, representing a 16.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Amyris since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Amyris historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Amyris

All Key Metrics — Amyris